Biogen Inc (BIIB)
$157.46 $0.06 (0.04%) 1:53 AM 12/12/24
NASDAQ | $USD | Drug Manufacturers - GeneralStock Data
-
Market Cap
$22.99B -
Day's Range
$153.68 - $156.40 -
Volume
1,449,403 -
52 Week Low / High
$153.62 - $268.30 -
PE Ratio
14.27x -
PEG Ratio
6.24 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 15
- Strong Buy
- 7
- Buy
- 13
- Hold
- 0
- Sell
- 0
- Strong Sell
- $330.76
- Target Price
Company News
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
State Street Corp's Strategic Acquisition of Biogen Inc Shares — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 250,487 shares of Biogen Inc (NASDAQ:BIIB), a prominent player in the biotechnology industry. This transaction increased State Street Corp's tot...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
Biogen (BIIB): Pioneering CNS Treatments and Future Growth Prospects — Oct 16th, 2024
We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a look at where Biogen (NASDAQ:BIIB) stands against other biggest stocks with negative beta to consider. Beta is a measureament of market risk or volatility that indicat...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Biogen (BIIB): Pioneering CNS Treatments and Future Growth Prospects — Oct 16th, 2024
We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a look at where Biogen (NASDAQ:BIIB) stands against other biggest stocks with negative beta to consider. Beta is a measureament of market risk or volatility that indicat...
-
State Street Corp's Strategic Acquisition of Biogen Inc Shares — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 250,487 shares of Biogen Inc (NASDAQ:BIIB), a prominent player in the biotechnology industry. This transaction increased State Street Corp's tot...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
State Street Corp's Strategic Acquisition of Biogen Inc Shares — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 250,487 shares of Biogen Inc (NASDAQ:BIIB), a prominent player in the biotechnology industry. This transaction increased State Street Corp's tot...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts? — Oct 20th, 2024
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions have focus...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now — Oct 20th, 2024
We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now.In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large cap stocks. The Fed recently reduced the funds rate by 50 basis points, a decision seen as dar...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
-
5 Healthcare Stocks to Buy in a Beaten-Up Sector — Nov 14th, 2024
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector SPDR Fund which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. In...
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
-
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce — Oct 17th, 2024
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression. The reorgan...
Portfolio
Comprised of 1 portfolios